Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Thornton & Ross Ltd - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3410
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Thornton & Ross Ltd (Thornton & Ross), a subsidiary of Stada Arzneimittel AG is a supplier of medicines and healthcare products. The company offers over the counter pharmaceutical products. It also manufactures pharmaceutical creams, liquids and semi-solids. Thornton & Ross’ products comprise cough syrups, sprays and disinfectants, antiseptic creams, baby products, pain relievers, skin care creams, antacids and chickenpox medicines. The company also offers drugs for indigestion problem. It sells its products through a network of distributors across the UK. Thornton & Ross is headquartered in Huddersfield, West Yorkshire, the UK.

Thornton & Ross Ltd – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Thornton & Ross Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Asset Purchase 10
Thornton & Ross Acquires Rights for Flexitol from LaCorium Health for USD17 Million 10
Licensing Agreements 11
Thornton & Ross Enters into Licensing Agreement with Futura Medical 11
Acquisition 12
Stada Arzneimittel Completes Acquisition Of Thornton & Ross, OTC Drug Maker, For US$339 Million 12
Thornton & Ross Ltd – Key Competitors 14
Thornton & Ross Ltd – Key Employees 15
Thornton & Ross Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Key Facts 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Thornton & Ross Ltd, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Thornton & Ross Ltd, Deals By Therapy Area, 2012 to YTD 2018 8
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Thornton & Ross Acquires Rights for Flexitol from LaCorium Health for USD17 Million 10
Thornton & Ross Enters into Licensing Agreement with Futura Medical 11
Stada Arzneimittel Completes Acquisition Of Thornton & Ross, OTC Drug Maker, For US$339 Million 12
Thornton & Ross Ltd, Key Competitors 14
Thornton & Ross Ltd, Key Employees 15
Thornton & Ross Ltd, Subsidiaries 16

List of Figures
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Thornton & Ross Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Thornton & Ross Ltd:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Endocyte Inc (ECYT):製薬・医療:M&Aディール及び事業提携情報
    Summary Endocyte Inc (Endocyte) is a biopharmaceutical company that develops targeted therapies for the treatment of cancer and inflammatory diseases. The company’s pipeline products include Lu-PSMA-617 and Ac-PSMA-617 for radiologand therapy, and FITC CAR-T. Endocyte's proprietary small molecule dr …
  • Zoll Medical Corporation:企業の戦略的SWOT分析
    Zoll Medical Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Tosoh Corp (4042):企業の財務・戦略的SWOT分析
    Tosoh Corp (4042) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Yes Bank Ltd:企業のM&A・事業提携・投資動向
    Yes Bank Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Yes Bank Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, …
  • Bright Horizons Family Solutions LLC (BFAM):企業の財務・戦略的SWOT分析
    Summary Bright Horizons Family Solutions LLC (Bright Horizons) is a provider of educational advisory services and child care services. The company offers curriculum and programs including early education and preschool, back-up child and adult care programs, infant care, toddler care, college coach, …
  • Osprey Medical Inc (OSP):医療機器:M&Aディール及び事業提携情報
    Summary Osprey Medical Inc (Osprey Medical) is a medical device company that designs, develops, and manufacturers proprietary devices and monitoring systems. The company offers contrast removal system, which is designed to provide cardiologists with an advanced level of CIN protection in high risk p …
  • TenneT Holding BV:企業の戦略的SWOT分析
    TenneT Holding BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • PT. Matahari Putra Prima Tbk (MPPA):企業の財務・戦略的SWOT分析
    PT. Matahari Putra Prima Tbk (MPPA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Lumosa Therapeutics Co Ltd (6535):製薬・医療:M&Aディール及び事業提携情報
    Summary Lumosa Therapeutics Co Ltd (Lumosa Therapeutics) is a developer of drugs for the treatment of neurological and inflammatory diseases. The company’s pipeline products include LT-1001, an analgesic injection for severe pain relief; and LT-3001, a novel small molecule for acute ischemic stroke. …
  • Global Investment House KPSC:企業の戦略的SWOT分析
    Global Investment House KPSC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Varta AG (VAR1):企業の財務・戦略的SWOT分析
    Varta AG (VAR1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Sensient Technologies Corp (SXT):企業の財務・戦略的SWOT分析
    Sensient Technologies Corp (SXT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • BioElectronics Corp (BIEL):企業の製品パイプライン分析2018
    Summary BioElectronics Corp (BioElectronics) is a medical device company that provides non-invasive electroceuticals for the mitigation of neurological diseases. It develops, manufactures and markets non-invasive, drug-free, disposable pain therapy devices. The company’s products for pain relief inc …
  • XuanZhu Pharma Co Ltd-製薬・医療分野:企業M&A・提携分析
    Summary XuanZhu Pharma Co Ltd (XuanZhu), a subsidiary of Sihuan Pharmaceutical Holdings Group Ltd is a healthcare company that research, develops, manufactures and sales drugs. The company’s products include anti-infective drugs apapenem and benapenem; anti-acid drug anaprazole sodium, anti-diabetic …
  • Versum Materials, Inc. (VSM):企業の財務・戦略的SWOT分析
    Versum Materials, Inc. (VSM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Harvard Bioscience Inc (HBIO):企業の財務・戦略的SWOT分析
    Harvard Bioscience Inc (HBIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Cognoptix Inc:医療機器:M&Aディール及び事業提携情報
    Summary Cognoptix Inc (Cognoptix), formerly Neuroptix Corp is a privately held medical technology company that develops and offers eye-scanning test for the early detection and diagnosis of Alzheimer’s disease. The company develops technology, which is used to detect the presence of Alzheimer’s rela …
  • Owens Corning (OC):企業の財務・戦略的SWOT分析
    Owens Corning (OC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Sinopec Oilfield Service Corp (600871):石油・ガス:M&Aディール及び事業提携情報
    Summary Sinopec Oilfield Service Corp (SOSC), formerly Sinopec Yizheng Chemical Fibre Company Ltd, is an integrated oil field service company. It operates as a subsidiary of China Petroleum & Chemical Corporation. The company provides integrated and full industrial-chain services covering the entire …
  • CRISPR Therapeutics:戦略・SWOT・企業財務分析
    CRISPR Therapeutics - Strategy, SWOT and Corporate Finance Report Summary CRISPR Therapeutics - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆